Ask AI

Curbside Consults in T2D Care: Translating Cardiometabolic Evidence Into Primary Care Decisions

Learn best practices for assessing cardiorenal risk in patients with type 2 diabetes (T2D) and integrating novel incretin-based T2D therapies to improve long-term adherence and outcomes, through an expert-written ClinicalThought, downloadable slides, text modules, and a podcast.

Share

Program Content

Activities

Cardiometabolic health in diabetes care
Enhancing Cardiometabolic Health in Diabetes Care With Incretin-Based Therapies
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: June 29, 2026

Expires: June 28, 2027

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk